Comprehensive Technical Assistance for Health Supply Chain and Pharmaceutical Management

The US Agency for International Development Bureau for Global Health awarded this Master IDIQ on January 8, 2024, to provide comprehensive technical assistance for health supply chain and pharmaceutical management globally, with ordering authority extending through January 7, 2034. The vehicle carries a $2.2 billion combined potential value ceiling and was structured as a multiple-award contract with approximately six awardees: four unrestricted and two set aside for small businesses.

Three task orders have been awarded to date, all under unrestricted competition, totaling $126.1 million in combined potential value with $11.8 million obligated (9 percent utilization). The three distinct awardees are JSI Research & Training Institute Inc. ($82.2 million potential value), DAI Global LLC ($24.5 million), and Management Sciences For Health, Inc. ($19.5 million). Ordering activity has slowed after an initial surge: three orders were placed in 2024, with the most recent award in December 2024. One task order (ESCAPE activity under Management Sciences For Health) was terminated for convenience in February 2025, signaling potential scope volatility.

Work encompasses supply chain strengthening, pharmaceutical management systems development, quality assurance support, and regulatory systems capacity building. Specific tasks include a Tanzania regional effort ($82.2 million ceiling, Cost Plus Fixed Fee), a Kenya integrated pharmaceutical and supply chain initiative ($24.5 million ceiling, Cost Plus Award Fee), and the West Africa regional program ($19.5 million ceiling, Cost Plus Fixed Fee, since terminated). Funding flows through USAID regional missions, with no single customer dominating: Tanzania, Kenya, and West Africa regional programs each hold one order.

The vehicle remains active with over seven years of ordering authority remaining. The relatively low obligated-to-potential ratio (9 percent) and modest annual ordering pace suggest the vehicle is in early deployment. Competitive pursuit is tractable given only three incumbents across a six-award vehicle, though the small-business set-aside component (two of six awardees) creates a separate competitive pool.

The purpose of Comprehensive TA is to strengthen systems and provide operational support to ensure sustainable access to and appropriate use of safe, effective, quality-assured, affordable health commodities. Comprehensive TA will work to develop the capacity of local systems, institutions, and individuals to sustainably manage supply chains, for both USAID-procured health commodities and those procured through other donor and national/local systems, and to strengthen local pharmaceutical management systems, including quality pharmaceutical services and national regulatory systems. This will include support for governments to shift from supply chain operators and pharmaceutical service providers to stewards for commodity and service availability and security, with heavier reliance on the private sector to provide operational support.